MabGenesis Inc. (TYO:653A)
Japan flag Japan · Delayed Price · Currency is JPY
635.00
-31.00 (-4.65%)
Nov 18, 2026, 11:09 AM JST

MabGenesis Company Description

MabGenesis Inc., a biopharmaceutical company, engages in the research, discovery, development, and commercialization of therapeutic monoclonal antibody drugs for human and animal healthcare applications in Japan.

The company offers proprietary antibody discovery platforms, including MOURA Libraries and IMPACT antibody isolation technology, to develop antibody therapeutics.

The company was incorporated in 2019 and is based in Yokohama, Japan.

MabGenesis Inc.
CountryJapan
Founded2019
IndustryBiotechnology
SectorHealthcare
CEOKatsuhiro Shinjo

Contact Details

Address:
3 Chome-7-18 Shinyokohama
Yokohama, 222-0033
Japan
Phone81 45 534 6033
Websitemabgenesis.com

Stock Details

Ticker Symbol653A
ExchangeTokyo Stock Exchange
Stock TypeCommon Stock
Reporting CurrencyJPY
ISIN NumberJP3870010000
SIC Code2834

Key Executives

NamePosition
Katsuhiro ShinjoChief Executive Officer